Strides Arcolab gets USFDA nod for Abacavir Sulfate Tablets

Strides Arcolab Limited (Strides) announced today that it has received tentative approval from the United – States – Food and Drug Administration for abbreviated new drug application (ANDA) for Abacavir Sulfate Tablets, 300mg under the expedited review provisions of the President’s Emergency Plant for AIDS Relief (PEPFAR).

The company supplies ARV products to global procurement agencies and this approval adds to the overall basket of medicines available.

About Strides Arcolab Limited:
Strides Arcolab, listed on the Bombay Stock Exchange Limited (532531) and National Stock Exchange of India Limited (STAR), is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures a wide range of IP-led niche pharmaceutical products with an emphasis on sterile injectables.

The company has 14 manufacturing facilities across 6 countries with presence in more than 75 countries in developed and emerging markets. Manufacturing is ably supported by a 350-scientist strong global R&D Centre located in Bangalore. Additional information is available at the company’s website at www.stridesarco.com.